ARVN
Overvalued by 153.4% based on the discounted cash flow analysis.
Market cap | $2.20 Billion |
---|---|
Enterprise Value | $1.03 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-5.9 |
Beta | 1.77 |
Outstanding Shares | 68,431,891 |
Avg 30 Day Volume | 708,569 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -6.19 |
---|---|
PEG | 40.58 |
Price to Sales | 32.68 |
Price to Book Ratio | 4.09 |
Enterprise Value to Revenue | 14.46 |
Enterprise Value to EBIT | -2.59 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data